Actively Recruiting
Metacognitive Training in Ultra-high Risk
Led by Medical University of Vienna · Updated on 2024-03-15
30
Participants Needed
2
Research Sites
131 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this pilot study is to examine whether metacognitive training can improve symptoms, wellbeing and functioning in individuals with attenuated psychotic symptoms. Metacognitive group training is an intervention designed to raise awareness on and change cognitive biases that may foster the development of psychotic symptoms such as delusions. It has been shown to be helpful in people with manifest psychosis. The main goal is to assess whether this training is prone to reducing symptoms in individuals at risk for psychosis. Participants will be randomized either to treatment as usual or to treatment as usual plus metacognitive training. Follow-ups will be performed over the period of one year.
CONDITIONS
Official Title
Metacognitive Training in Ultra-high Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 16 and 40 years
- Individuals with attenuated psychotic symptoms occurring several times per week within the last year and lasting at least one week but no longer than five years
- Individuals with brief limited intermittent psychotic symptoms lasting less than one week and spontaneously resolved
- Ability to give informed consent and follow study procedures
You will not qualify if you...
- Past psychotic episode lasting one week or longer, treated or untreated
- Recent increase in antipsychotic medication dose within the last two weeks or clinical need for dosage increase at inclusion
- Past neuroleptic exposure exceeding lifetime haloperidol dose of 50 mg equivalent
- Acute suicidality or aggressive behavior
- Current symptoms fully explained by acute intoxication
- Organic brain disease such as epilepsy or inflammatory brain disease
- Unstable physical illness with psychotropic effects
- Diagnosis of serious developmental disorder like Asperger's syndrome
- Premorbid IQ below 70
- Inadequate knowledge of the German language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Department of Child and Adolescent Psychiatry
Vienna, Austria
Actively Recruiting
2
Department of Psychiatry and Psychotherapy
Vienna, Austria
Actively Recruiting
Research Team
N
Nilufar Mossaheb, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here